[Pharmacoeconomic evaluation of spinal muscular atrophy therapy in patients with four SMN2 copies diagnosed through newborn screening].
- DOI
- 10.17116/jnevro2025125121188
- Published
- 2025
- Container
- Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.17116/jnevro2025125121188,
title = {[Pharmacoeconomic evaluation of spinal muscular atrophy therapy in patients with four SMN2 copies diagnosed through newborn screening].},
author = {Avxentyev NA and Makarov AS and Germanenko OY and Vlodavets DV and Kuzenkova LM},
year = {2025},
journal = {Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova},
doi = {10.17116/jnevro2025125121188},
url = {https://doi.org/10.17116/jnevro2025125121188}
}RIS
TY - JOUR TI - [Pharmacoeconomic evaluation of spinal muscular atrophy therapy in patients with four SMN2 copies diagnosed through newborn screening]. AU - Avxentyev NA AU - Makarov AS AU - Germanenko OY AU - Vlodavets DV AU - Kuzenkova LM PY - 2025 JO - Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova DO - 10.17116/jnevro2025125121188 UR - https://doi.org/10.17116/jnevro2025125121188 ER -
APA
NA, A., AS, M., OY, G., DV, V., & LM, K. (2025). [Pharmacoeconomic evaluation of spinal muscular atrophy therapy in patients with four SMN2 copies diagnosed through newborn screening].. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. https://doi.org/10.17116/jnevro2025125121188
Source records
- pubmed · retrieved 2026-09-26T18:07:31.248Z